Nafamostat Mesylate in the Prevention of Post-endoscopic Retrograde Cholangiography Pancreatitis: A Meta-analysis
Hyder Osman Mirghani, Abdelwahab Hassan Abdelwahab Hussien & Abdullah Suliman Al Atawi · Journal of Pharmaceutical Research International · 2022
Previous evidence from observational studies showed that Nafamostat mesylate (NM) was effective in post-ERCP pancreatitis prevention. We aimed to assess full-text prospective studies on the role of NM in post-ERCP pancreatitis prevention. We searched the PubMed, Medline, and Goog...
Open access
Research Article
10.9734/jpri/2022/v34i28A36021